HOME >> BIOLOGY >> NEWS
University of Kentucky awarded $6 million for GDNF and related research

The University of Kentucky Morris K. Udall Parkinson's Disease Research Center of Excellence has been awarded nearly $6 million from National Institutes of Health and National Institute of Neurological Disorders and Stroke to continue work on the promising drug glial cell line-derived neurotrophic factor (GDNF) and similar compounds.

Greg Gerhardt, Ph.D., professor, Department of Anatomy and Neurobiology and Department of Neurology, director of the Morris K. Udall Parkinson's Disease Research Center of Excellence, and director of the Center for Sensor Technology, has headed the Udall Center at UK since its inception six years ago. As one of only 12 Udall Centers in the nation, UK's center represents the leading edge of research into Parkinson's disease, which at this point remains an incurable condition.

GDNF differs from other Parkinson's therapies in that it has demonstrated potential to halt or perhaps reverse the neurodegenerative condition. Current treatments only provide temporary relief from symptoms.

"The NINDS is pleased to continue the support of the University of Kentucky Udall Center, a unique component of the Udall center program that provides non-human primate studies of potential therapeutics in Parkinson's disease," said Diane Murphy, Ph.D., Program Director for the NINDS' Morris K. Udall Parkinson's Disease Research Centers of Excellence.

Gerhardt and colleagues will spend the next five years investigating potential negative effects of GDNF, and how to fine tune dosing and administration techniques to make the therapy a safer and more viable alternative.

The $6 million funding from NIH represents a vote of confidence for the UK Udall Center and its work to date on GDNF and related molecules. At the end of this five-year funding cycle UK researchers plan to be ready to move GDNF or a related compound once again into human clinical trials a timetable considered ambitious by industry standards, but realistic to Gerhardt.


'"/>

Contact: Allison Elliott
allison.elliott@uky.edu
859-257-1754
University of Kentucky
12-Sep-2005


Page: 1 2 3

Related biology news :

1. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. Biologists at Tufts University discover 1 reason why chromosomes break, often leading to cancer
4. $9M grant awarded to University of Cincinnati for bipolar disorder research
5. University of Leeds strengthens China links in membrane and neurobiology
6. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
7. Manchester University helps with pharaoh DNA analysis
8. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
9. University of Arizona launches major scientific research initiative at Biosphere 2
10. Link between obesity and enlarged heart discovered by University of Arizona researchers
11. Bee researcher at Arizona State University is 1 of 20 new Pew Scholars in the biomedical sciences

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... ... July 21, 2020 , ... USDM Life ... and compliance, announces a new solution to manage regulated workloads on Microsoft Azure. ... their technology stack complies with FDA and global regulations. USDM's new managed service ...
(Date:7/10/2020)... ... ... Today CJ BIO announced the first in a series of Food Ingredient MasterClass webinars, ... revolutionizing ingredient mixes, nutritional content and flavor profiles across a range of savory foods ... AM (CDT) during SHIFT20, the virtual edition of the IFT Annual Meeting & Food ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... making available for free its new white paper – Simulated Transport Methodologies. ... into today’s biologics licensing application (BLA). In response, Modality Solutions shares an ...
(Date:8/3/2020)... ... , ... ERT, the global leader in clinical ... one of the 100 most inspiring individuals in the life-sciences industry by PharmaVoice. ... on how they have inspired their colleagues and affected positive changes in their ...
(Date:7/31/2020)... ... 29, 2020 , ... G-CON Manufacturing, the leader in off-site ... FOR LIFE.” The adoption of this taglines comes at a time of tremendous ... to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. G-CON’s ...
(Date:7/31/2020)... SOMERSET, N.J (PRWEB) , ... July 29, 2020 ... ... editing company, and Catalent, the leading global provider of advanced delivery technologies, development, ... products, today announced that they have entered into a strategic partnership whereby Catalent ...
Breaking Biology Technology:
Cached News: